What is the management of ST-Elevation Myocardial Infarction (STEMI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of ST-Elevation Myocardial Infarction (STEMI)

Primary percutaneous coronary intervention (PCI) is the recommended first-line reperfusion strategy for STEMI patients when it can be performed within 90 minutes of first medical contact by experienced operators. 1

Initial Assessment and Immediate Management

  • Immediate actions upon STEMI diagnosis:
    • Administer 162-325 mg of non-enteric coated aspirin (chewed) immediately 1
    • Add loading dose of P2Y12 inhibitor:
      • Preferred: Ticagrelor 180 mg or Prasugrel 60 mg
      • Alternative: Clopidogrel 600 mg 1
    • Start anticoagulation immediately:
      • Enoxaparin (preferred): 30 mg IV bolus followed by 1 mg/kg SC every 12 hours
      • Unfractionated heparin: 60 U/kg IV bolus followed by 12 U/kg/hour infusion
      • Bivalirudin: Alternative especially for patients with high bleeding risk 1
    • Administer supplemental oxygen if arterial saturation <90% 1
    • Consider morphine for pain and pulmonary congestion 1

Reperfusion Strategy Decision Algorithm

  1. Can primary PCI be performed within 120 minutes of first medical contact?
    • YES → Proceed with primary PCI

      • For patients <75 years with large anterior infarction presenting within 2 hours, aim for PCI within 90 minutes 1
      • Transport directly to PCI-capable hospital with goal first medical contact-to-device time ≤90 minutes 1
      • Bypass emergency departments when possible to reduce door-to-balloon time 1
    • NO → Administer fibrinolytic therapy within 30 minutes of first medical contact

      • Use fibrin-specific agent (tenecteplase, alteplase, or reteplase) 1
      • Transfer patient immediately to PCI-capable center after fibrinolysis 1
      • Perform angiography and PCI of infarct-related artery 2-24 hours after successful fibrinolysis 1
      • Monitor for signs of failed fibrinolysis and be prepared for rescue PCI 1

Important Time Considerations

  • Thrombolysis efficacy decreases significantly with time:
    • 51% mortality reduction when given within 1 hour of symptom onset
    • 20% reduction when given between 3-6 hours 1
    • Most beneficial within first 3 hours (approximately 30 early deaths prevented per 1000 patients) 1

Contraindications to Thrombolysis

  • Prior intracranial hemorrhage
  • Known cerebrovascular lesion
  • Recent major trauma or surgery
  • Active bleeding or bleeding diathesis
  • Suspected aortic dissection 1

Post-Reperfusion Medical Therapy

  • Before discharge, initiate:
    • Beta-blockers (start with low doses and titrate if heart failure present) 1
    • ACE inhibitors with low initial dose unless systolic BP <100 mmHg 1
    • Nitrates unless systolic BP <100 mmHg 1
    • Consider aldosterone blockade for patients with LVEF ≤0.40 and either symptomatic heart failure or diabetes 1
    • Consider diuretics if volume overload present 1
    • Discontinue NSAIDs (except aspirin) due to increased risks 1

Secondary Prevention

  • Continue dual antiplatelet therapy for at least 12 months after PCI 1
  • Maintain statin therapy, beta-blockers, and ACE inhibitors (for indicated patients) 1
  • Provide smoking cessation counseling, weight management, and physical activity recommendations 1
  • Refer to cardiac rehabilitation 1
  • Manage diabetes (goal HbA1c <7%) and blood pressure (goal <140/90 mmHg or <130/80 mmHg for CKD/diabetes) 1

Special Considerations

  • For patients presenting 12-24 hours after symptom onset, PCI may still be beneficial if signs of ischemia/viability in the infarct-related area are present 2
  • Patients with transient STEMI (resolution of symptoms and ECG changes before reperfusion) still benefit from early invasive approach with intense medical therapy 3

Pitfalls to Avoid

  • Delaying reperfusion therapy - outcomes worsen significantly with time
  • Failing to transfer patients to PCI-capable centers after fibrinolysis
  • Overlooking dose adjustments for anticoagulants in patients with renal insufficiency 1
  • Administering GP IIb/IIIa inhibitors "upstream" rather than selectively for high intracoronary thrombus burden 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.